Bradley Merrill Thompson serves as Chairman of the Board and Chief Data Scientist of EBG Advisors, Inc.  Mr. Thompson has more than 30 years of experience working with medical device, drug, and combination product companies on a wide range of FDA regulatory and reimbursement issues. As Chief Data Scientist, in addition to working with clients bringing artificial intelligence (AI)-driven medical products to market, Brad collaborates with other attorneys and consultants in such diverse areas as antitrust, employment law, and health care reimbursement, where data analysis plays a key role in successfully serving the client’s needs. For trade associations, Mr. Thompson has served as counsel to AdvaMed and the Continua Health Alliance; as General Counsel to the Combination Products Coalition, mHealth Regulatory Coalition, and the CDS Coalition; and as General Counsel and Secretary for the Indiana Medical Device Manufacturers Council.

Representative Experience

Mr. Thompson is a quantitative thinker by nature, who enjoys tinkering with algorithms. To develop a deeper understanding of machine learning algorithms, Mr. Thompson has returned to the University of Michigan, part time and using distance learning avenues, to pursue a Master in Applied Data Science from the School of Information. As a part of that curriculum, Mr. Thompson is studying the math, statistics, and computer science (Python), which serve as the basis for AI. Specific coursework includes SQL & Databases, SQL Architectures & Technologies, Efficient Data Processing, Scalable Data Processing, Math Methods for Data Science, Data Mining, Supervised Learning, Unsupervised Learning, Deep Learning, Machine Learning Pipelines, Natural Language Processing, and Network Analysis.  Mr. Thompson expects to graduate in 2021.

At EBG Advisors, Mr. Thompson leads an initiative to comprehensively serve the legal needs of those clients that either develop or use AI tools. That initiative cuts across the firm’s practice areas to include both health and labor.

In his own practice, Mr. Thompson regularly advises developers of new “software as a medical device” (or “SaMD”) products seeking FDA approval through the de novo process, the 510(k) process, and even in tandem with drug products. In this regard, he has been deeply involved in some of the most innovative technologies in this space both in the United States and internationally. Throughout 2019, Mr. Thompson visited eight of the leading engineering schools across the country to meet with students and alumni to teach them about the FDA requirements associated with bringing new AI-based medical device products to market. Over a thousand entrepreneurs signed up. Building on that momentum, Mr. Thompson founded the AI Startups in Health Coalition (AISHC) to help ensure that startup companies addressing clinical needs have a voice in FDA’s future plans to regulate AI, including FDA’s policymaking on its software precertification program as well as its good machine learning practices initiative. Mr. Thompson has published and spoken widely on these topics.

Memberships & Affiliations

  • American Bar Association
  • American Bar Foundation, Fellow
  • Food and Drug Law Institute
  • Regulatory Affairs Professional Society


Mr. Thompson was elected by his peers as a Fellow of the American Bar Foundation, and he has received an "AV Preeminent" Peer Review Rating by Martindale-Hubbell, signifying the highest level of professional excellence. He was selected by his peers for inclusion in The Best Lawyers in America© (2015 to 2022) in the field of FDA Law and included on the Indiana Super Lawyers list (2004 to 2006) and Washington DC Super Lawyers list (2013 to 2021) in the areas of Food and Drugs, Administrative Law, and Health Care. He was included in 100 Notable People in the Medical Device Industry (Medical Device & Diagnostics Industry, June 2004) and has been listed in Chambers USA: America's Leading Lawyers for Business (2010 to 2017). Additionally, Mr. Thompson was recommended in the Life Sciences category by The Legal 500 United States (2014).


  • University of Michigan Law School  (J.D., cum laude)
  • University of Illinois  (M.B.A.)
  • University of Illinois  (B.A., cum laude)